Lv7
4850 积分 2023-11-10 加入
Alectinib in Resected ALK-Positive Non-Small-Cell Lung Cancer
25天前
已完结
Ensartinib in Resected ALK -Positive Non–Small-Cell Lung Cancer
26天前
已完结
Updated overall survival and final progression-free survival data for patients with treatment-naive advanced ALK-positive non-small-cell lung cancer in the ALEX study
26天前
已完结
1787MO Updated results from the phase III ALINA study of adjuvant alectinib vs chemotherapy (chemo) in patients (pts) with early-stage ALK+ non-small cell lung cancer (NSCLC)
27天前
已完结
Safety issues with the ALK inhibitors in the treatment of NSCLC: A systematic review
28天前
已完结
Discovery of (10 R )-7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro- 2H -8,4-(metheno)pyrazolo[4,3- h ][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a Macrocyclic Inhibitor of Anaplastic Lymphoma Kinase (ALK) and c-ros Oncogene 1 (ROS1) with Preclinical Brain Exposure and Broad-Spectrum Potency against ALK-Resistant Mutations
28天前
已完结
Dimensionality Reduction of Single-Cell RNA Sequencing Data by Combining Entropy and Denoising AutoEncoder
28天前
已完结
Microbiome-transcriptome-histology triad enhances survival risk stratification in multiple cancers
28天前
已完结
Pathological image profiling identifies onco-microbial, tumor immune microenvironment, and prognostic subtypes of colorectal cancer
28天前
已完结
Anaphylaxis caused by pegylated recombinant human granulocyte colony-stimulating factor
29天前
已完结
皖公网安备34019202002308
